Related references
Note: Only part of the references are listed.Developmental endothelial locus-1 protects from hypertension-induced cardiovascular remodeling via immunomodulation
Theresa Failer et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Pregnancy induced TMA in severe preeclampsia results from complement-mediated thromboinflammation
A. Inkeri Lokki et al.
HUMAN IMMUNOLOGY (2021)
Endogenous DEL-1 restrains melanoma lung metastasis by limiting myeloid cell-associated lung inflammation
Young-Min Hyun et al.
SCIENCE ADVANCES (2020)
DEL-1-Regulated Immune Plasticity and Inflammatory Disorders
George Hajishengallis et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Serum developmental endothelial locus-1 is associated with severity of sepsis in animals and humans
Won-Young Kim et al.
SCIENTIFIC REPORTS (2019)
Placenta derived factors involved in the pathogenesis of the liver in the syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP): A review
L. C. E. W. van Lieshout et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2019)
DEL-1 promotes macrophage efferocytosis and clearance of inflammation
Ioannis Kourtzelis et al.
NATURE IMMUNOLOGY (2019)
Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche
Ioannis Mitroulis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Endogenous developmental endothelial locus-1 limits ischaemia-related angiogenesis by blocking inflammation
Anne Klotzsche-von Ameln et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes
Venkata. S. Sabbisetti et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Developmental endothelial locus-1 attenuates complement-dependent phagocytosis through inhibition of Mac-1-integrin
Ioannis Mitroulis et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Complement activation and regulation in preeclamptic placenta
Anna Inkeri Lokki et al.
FRONTIERS IN IMMUNOLOGY (2014)
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss
Mehmet A. Eskan et al.
NATURE IMMUNOLOGY (2012)
Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
Vishal S. Vaidya et al.
NATURE BIOTECHNOLOGY (2010)
The HELLP syndrome: Clinical issues and management. A Review
Kjell Haram et al.
BMC PREGNANCY AND CHILDBIRTH (2009)
Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell Recruitment
Eun Young Choi et al.
SCIENCE (2008)
Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome
J. J. J. Hulstein et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Preeclampsia: A renal perspective
SA Karumanchi et al.
KIDNEY INTERNATIONAL (2005)
Developmental endothelial locus-1 (Del-1), a novel angiogenic protein - Its role in ischemia
HKV Ho et al.
CIRCULATION (2004)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension
SK Nadar et al.
THROMBOSIS RESEARCH (2004)
Share Paper
